← FDA Drug Approvals (Drugs@FDA)
ELIQUIS
NDA · New Drug Application · Sponsor: BRISTOL · Approved 2025-04-17
Drug application
- FDA Application #
NDA220073- Application type
- New Drug Application
- Brand name
- ELIQUIS
- Generic name
- Apixaban
- Active ingredients
- APIXABAN
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- BRISTOL
- First approval
- 2025-04-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown